Insider Trading - Watson Ashley

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Watson Ashley

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-10-31
Sale
2018-11-01
5:07 pm
Merck & Co. Inc. MRK Watson Ashley
CEO
47,036 $74.33 $3,496,158 30,429
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2018-02-27
Option Award
2018-03-01
7:32 pm
N/A
N/A
Merck & Co. Inc. MRK Watson Ashley
CEO
2,322 $54.72 2,466
(Direct)
View
2018-05-01
Exercise
2018-05-02
12:19 pm
N/A
N/A
Merck & Co. Inc. MRK Watson Ashley
CEO
10,441 $0 9,821
(Direct)
View
2018-05-01
Exercise
2018-05-02
12:19 pm
2018-05-01
2018-05-01
Merck & Co. Inc. MRK Watson Ashley
CEO
10,441 $58.87 9,821
(Direct)
View
2018-05-01
Tax Withholding
2018-05-02
12:19 pm
N/A
N/A
Merck & Co. Inc. MRK Watson Ashley
CEO
3,151 $58.87 9,821
(Direct)
View
2018-05-04
Option Award
2018-05-08
5:33 pm
2019-05-04
2021-05-04
Merck & Co. Inc. MRK Watson Ashley
CEO
20,895 $0 30,716
(Direct)
View
2018-10-31
Exercise
2018-11-01
5:07 pm
N/A
N/A
Merck & Co. Inc. MRK Watson Ashley
CEO
5,706 $63.97 30,429
(Direct)
View
2018-10-31
Exercise
2018-11-01
5:07 pm
N/A
N/A
Merck & Co. Inc. MRK Watson Ashley
CEO
18,110 $54.68 30,429
(Direct)
View
2018-10-31
Exercise
2018-11-01
5:07 pm
2016-05-01
2025-04-30
Merck & Co. Inc. MRK Watson Ashley
CEO
47,036 $0 30,429
(Direct)
View
2018-10-31
Exercise
2018-11-01
5:07 pm
N/A
N/A
Merck & Co. Inc. MRK Watson Ashley
CEO
23,220 $59.86 30,429
(Direct)
View